Latest stories on MBX
MBX Biosciences Announces CEO Transition and Leadership Updates
TipRanks50 · neutralgeneral
MBX Biosciences, Inc. (MBX) files 8-K
SEC 8-K50 · neutralgeneral
MBX Biosciences appoints Steve Hoerter as CEO and John Smither as CFO
Seeking Alpha55 · neutralgeneral
MBX Biosciences Announces Executive Leadership Transition to Support the Company’s Next Phase of Growth
Business Insider56 · neutralgeneral
MBX Biosciences: Weekly PTH, Monthly Obesity, Multi-Year Upside (Initiating Buy)
Seeking Alpha63 · neutralanalyst
MBX Biosciences Completes STEADI Trial, Putting Imapextide on Investors’ Radar
TipRanks67 · bullishproduct/pr
Health Care Roundup: Market Talk
Yahoo Finance50 · neutralgeneral
MBX Biosciences, Inc. (MBX) Discusses One-Year Data From Phase II Open-Label Extension Study of Once-Weekly Canvuparatide Transcript
Seeking Alpha56 · neutralproduct/pr
MBX updates data from mid-stage trial for endocrine disease therapy
Seeking Alpha38 · neutralproduct/pr
MBX Biosciences, Inc. (MBX) Discusses One-Year Data From Phase II Open-Label Extension Study of Once-Weekly Canvuparatide - Slideshow
Seeking Alpha59 · neutralproduct/pr
MBX Biosciences Shows Sustained One-Year Benefit of Once-Weekly Canvuparatide for Chronic Hypoparathyroidism
MarketChameleon67 · bullishproduct/pr
MBX Biosciences unveils positive Phase 2 canvuparatide results
TipRanks73 · bullishproduct/pr
MBX Biosciences, Inc. (MBX) files 8-K
SEC 8-K50 · neutralgeneral
MBX Biosciences: In Danger Of Being Outpaced By Rivals - Rating Downgrade
Seeking Alpha34 · bearishgeneral
MBX Biosciences to Host Virtual Investor Event to Discuss Once-Weekly Canvuparatide Presentations at ENDO 2026 | MBX Stock News
StockTitan63 · neutralproduct/pr
Chief Medical Officer Sells MBX for $2.7 Million After Monster 2026 Run
Yahoo Top42 · neutralgeneral
MBX Biosciences to Present at the Jefferies 2026 Global Healthcare Conference in New York City | MBX Stock News
StockTitan56 · neutralgeneral